Skip to content

Pilot Study of Coil Arrays in Patients With Advanced Solid Tumor Malignancies

A Pilot Study of Novel Magnetic Resonance Coil Arrays to Improve the Characterization of Liver Metastases in Patients With Advanced Solid Tumor Malignancies

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02390011
Enrollment
7
Registered
2015-03-17
Start date
2015-01-08
Completion date
2015-05-16
Last updated
2022-03-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neoplams

Keywords

Advanced Solid Tumor

Brief summary

This is a single center pilot study testing the use of novel coil arrays with MR liver imaging. In part A of the study, up to 30 healthy volunteers will be scanned, with iterative adjustment of coil array geometry and design to optimize imaging characterstics. In Part B of the study, 40 patients with advanced solid tumors and at least one liver metastasis measuring \> 1.5 cm in diameter on standard anatomic scans will undergo MR liver imaging with the newly designed coil array, with the use of gadolinium contrast. Patients with liver tumors will have the option of undergoing a second MR liver scan during the course of subsequent systemic therapy.

Interventions

PROCEDUREMRI

Sponsors

University of California, San Francisco
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

(Part B only - Patients with advanced solid tumor): * Advanced solid tumor malignancy and the presence of at least one liver metastasis measuring \> 1.5 cm in longest diameter in axial dimension on standard anatomic imaging

Exclusion criteria

(Part B only): * Contra-indication to gadolinium contrast (e.g. chronic renal disease, prior allergic reaction) for patient studies

Design outcomes

Primary

MeasureTime frameDescription
Spatial ResolutionDay 1Adjust the coil array to optimize spatial resolution in healthy volunteers
Scan coverageDay 1Adjust the coil array to optimize scan coverage of the liver in healthy volunteers
Mean contrast-to-noise ratioDay 1Detectable using the coil array

Secondary

MeasureTime frameDescription
Minimum size of detectable metastatic lesionDay 1Detected by MRI scan
Degree signalDay 1Detected by gandolinium contrast in MRI scan within liver metastases
Time-to-peak signalDay 1Detected by gandolinium contrast in MRI scan within liver metastases

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026